ECHELON-2研究：Brentuximab Vedotin联合CHP方案一线治疗CD30表达阳性的外周T细胞淋巴瘤的疗效分析
ECHELON-2 Study： Curative Effect Analysis of Brentuximab Vedotin with CHP Chemotherapy for CD30-Positive Peripheral T-Cell Lymphoma
ECHELON-2研究：Brentuximab Vedotin联合CHP方案一线治疗CD30表达阳性的外周T细胞淋巴瘤的疗效分析 |
| 评价者:杨春丽, 邹立群 |
ECHELON-2 Study： Curative Effect Analysis of Brentuximab Vedotin with CHP Chemotherapy for CD30-Positive Peripheral T-Cell Lymphoma |
| |